GLTO
Galecto Inc
NASDAQ: GLTO · HEALTHCARE · BIOTECHNOLOGY
$25.66
+7.23% today
Updated 2026-04-30
Market cap
$43.73M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-12.11
Dividend yield
—
52W range
$2 – $38
Volume
0.3M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$32.00
+24.71%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.62M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-51.75M | $-61.62M | $-38.35M | $-21.44M | $-3.13M |
| EPS | — | — | — | — | $-12.11 |
| Free cash flow | $-52.53M | $-43.13M | $-36.99M | $-18.62M | $-2.62M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Galecto Inc trades at $25.66. Our Smart Value Score of 16/100 indicates the stock is weak.
Frequently asked questions
What is Galecto Inc's stock price?
Galecto Inc (GLTO) trades at $25.66.
Is Galecto Inc overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Galecto Inc (GLTO)?
The analyst target price is $32.00, representing +24.7% upside from the current price of $25.66.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-1.10%
Beta1.41
50D MA$12.85
200D MA$5.73
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—